Contract research CDMO stocks
Heavily traded in Contract research CDMO
Turnover over $10M/day18 of about 60 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| 207940.KSSamsung Biologics Co.,Ltd. | $61.81B | −26.92% | Jan 20, 2027 |
| IQVIQVIA Holdings Inc. | $359.12M | +26.27% | — |
| 4901.TFUJIFILM Holdings Corporation | $14.02B | −2.32% | Reports Nov 9, 2026 |
| MEDPMedpace Holdings, Inc. | $150.32M | +15.91% | — |
| CRLCharles River Laboratories International, Inc. | $333.04M | +108.77% | Reports Nov 4, 2026 |
| ICLRICON Public Limited Company | $174.12M | +29.85% | — |
| HALOHalozyme Therapeutics, Inc. | $248.19M | +101.01% | Reports Nov 5, 2026 |
| SHCSotera Health Company | $34.33M | +12.79% | Reports Nov 3, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
55 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 207940.KS | Samsung Biologics Co.,Ltd. | $47.53B | Large cap | −26.92% |
| IQV | IQVIA Holdings Inc. | $45.33B | Large cap | +26.27% |
| 4901.T | FUJIFILM Holdings Corporation | $26.34B | Large cap | −2.32% |
| MEDP | Medpace Holdings, Inc. | $18.95B | Large cap | +15.91% |
| CRL | Charles River Laboratories International, Inc. | $17.95B | Large cap | +108.77% |
| ICLR | ICON Public Limited Company | $16.14B | Large cap | +29.85% |
| HALO | Halozyme Therapeutics, Inc. | $14.89B | Large cap | +101.01% |
| 0ILL.L | Laboratorios Farmaceuticos Rovi, S.A. | $5.97B | Mid cap | −4.47% |
| STVN | Stevanato Group S.p.A. | $5.53B | Mid cap | −21.55% |
| SHC | Sotera Health Company | $5.34B | Mid cap | +12.79% |
| FTRE | Fortrea Holdings Inc. | $2.20B | Mid cap | +121.60% |
| 302440.KS | SK bioscience Co.,Ltd. | $1.89B | Small cap | −36.84% |
| KE | Kimball Electronics, Inc. | $648.02M | Small cap | −8.38% |
| ACRS | Aclaris Therapeutics, Inc. | $582.91M | Small cap | +70.51% |
| EVO | Evotec SE | $561.51M | Small cap | −61.93% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | $400.85M | Small cap | +7.91% |
| 005250.KS | GC Corp. | $309.90M | Small cap | −41.05% |
| LFCR | Lifecore Biomedical, Inc. | $247.15M | Small cap | −7.65% |
| 2475.T | WDB Holdings Co., Ltd. | $206.94M | Small cap | +6.23% |
| 008490.KS | Suheung Co., Ltd. | $149.66M | Small cap | −33.78% |
| 8095.T | Astena Holdings Co., Ltd. | $135.09M | Small cap | +18.58% |
| CDXS | Codexis, Inc. | $133.60M | Small cap | −49.59% |
| SLV.WA | Selvita S.A. | $106.58M | Small cap | −49.73% |
| 2927.T | AFC-HD AMS Life Science Co., Ltd. | $79.51M | Micro cap | +2.52% |
| CSBR | Champions Oncology, Inc. | $66.95M | Micro cap | −28.85% |
| 6568.T | KNC Laboratories Co., Ltd. | $62.08M | Micro cap | +15.50% |
| CTE.AX | Cryosite Limited | $41.91M | Micro cap | +2.52% |
| 7079.T | WDB coco Co., Ltd. | $39.00M | Micro cap | −0.51% |
| NSYS | Nortech Systems Incorporated | $32.10M | Micro cap | +14.18% |
| 2183.T | Linical Co., Ltd. | $28.33M | Micro cap | −39.89% |
| 2342.T | Transgenic Group Inc. | $22.58M | Micro cap | +10.26% |
| IXI.L | IXICO plc | $22.46M | Micro cap | −35.42% |
| IDT.AX | IDT Australia Limited | $13.61M | Micro cap | −23.73% |
| 6190.T | PhoenixBio Co., Ltd. | $7.48M | Micro cap | −45.40% |
| NAII | Natural Alternatives International, Inc. | $6.95M | Micro cap | −60.50% |
| EPN.AX | Epsilon Healthcare Limited | $5.75M | Micro cap | −12.50% |
| GELS | Gelteq Limited | $5.42M | Micro cap | −57.83% |
| SCNI | Scinai Immunotherapeutics Ltd. | $722.76K | Micro cap | −64.24% |
| 0RB1.L | Laboratorio Reig Jofre, S.A. | — | — | −13.53% |
| ALECR.PA | Eurofins-Cerep SA | — | Small cap | +4.55% |
| ALTAO.PA | Aton | — | — | +71.05% |
| BANB.SW | Bachem Holding AG | — | — | +54.05% |
| DESN.SW | Dottikon ES Holding AG | — | — | −14.38% |
| EAPI.PA | Euroapi S.A. | — | Small cap | −75.59% |
| EVT.DE | Evotec SE | — | Small cap | −60.71% |
| FAB.L | Fusion Antibodies plc | — | — | −58.62% |
| GXI.DE | Gerresheimer AG | — | Small cap | +20.12% |
| HVO.L | hVIVO plc | — | — | −15.94% |
| LONN.SW | Lonza Group AG | — | — | +12.05% |
| MAB.WA | Mabion S.A. | — | Small cap | −4.76% |
| OXB.L | Oxford Biomedica plc | — | Small cap | −11.13% |
| PPGN.SW | PolyPeptide Group AG | — | — | +86.26% |
| PRM.L | Proteome Sciences plc | — | — | −25.38% |
| PYC.L | Physiomics Plc | — | — | +11.76% |
| SFZN.SW | Siegfried Holding AG | — | — | −9.13% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 55 companies grouped under the Contract research CDMO theme. The median market value in the group is $178.30M. Among the 18 with a price from the latest session, the median move over the past trading day is −0.75%. 42% of the 55 with a 200-day average trade above it. Price change over the past year runs from −58.3% to +63.9% across the middle 80 percent of the group, with a median of −7.7%.